Philip W. Stashak

Separation of immunomodulatory effects of mannan from Candida albicans into stimulatory and suppressive components

Mannan extracted from Candida albicans was studied for its immunomodulatory activity on in vivo antibody responses to type III pneumococcal polysaccharide (SSS-III), a helper-T-cell-independent antigen, and to sheep erythrocytes (SRBC), a helper-T-cell-dependent antigen. In some studies, the antibody response to SSS-III was converted to a helper-T-cell-dependent response by attaching it to a carrier (horse erythrocytes, HRBC); this complex then was used to immunize mice primed with a subimmunogenic dose of HRBC. Mannan enhanced the antibody response to both SSS-III and SRBC when administered at the same time or 1 or 2 days after immunogen. However, when both mannan and SSS-III were coated onto HRBC for immunization, either enhancement or suppression was noted; the effect depended upon the amount of mannan used. Larger amounts stimulated, whereas smaller amounts suppressed, the antibody response to SSS-III. The enhancing and suppressive components of mannan could be separated by molecular size or charge by chromatography on Sepharose 4B or on DEAE-Sephadex A-50 columns, indicating that mannan extracts contain individual components having opposing immunomodulatory properties. These components can be separated on the basis of molecular size and charge.

IMMUNOLOGICAL PARALYSIS TO TYPE III PNEUMOCOCCAL POLYSACCHARIDE AS ASSESSED BY AN IMMUNO‐PLAQUE PROCEDURE

Two mechanisms have been proposed to explain the development of immunological paralysis or tolerance to pneumococcal polysaccharides. These deal with whether paralysis is the result of the neutralization of antibody by persistent undegraded antigen (the “treadmill” hypothesis) ,l or whether a suppression of antibody synthesis, i.e., a central failure of the immune mechanism, is involved.z These proposed mechanisms are not necessarily mutually exclusive and persuasive evidence has been advanced to support both points of view.l> 3-7 However, in order to evaluate fully the significance of either process in the development of paralysis, more precise quantitative information is required concerning the antibody response to pneumococcal polysaccharides at the cellular level. Recently, we developed an adaptation of the technique of localized hemolysisin-gel that permits one to determine not only the number of antibody-forming cells produced in response to pneumococcal polysaccharides but also the rate at which antibody is synthesized and released by such cells.x,9 By means of this method we have been able to show that while the neutralization of antibody by excess antigen may be a factor in the development of paralysis to large doses of pneumococcal polysaccharides, a central failure of the immune mechanism clearly plays a significant, if not a dominant, role.

Strain differences in the ability of antithymocyte serum (ATS) to enhance the antibody response of inbred mice to type III pneumococcal polysaccharide

Abstract Treatment with antithymocyte serum (ATS), prepared in burros or rabbits, significantly enhanced the antibody response to Type III pneumococcal polysaccharide (SSS-III) in 5 inbred and 2 hybrid strains of mice. The degree of enhancement attained depended upon the dose of ATS employed. Strains of mice differed with respect to the amount of enhancement produced following treatment with a given dose of the same preparation of ATS.

The role of antigen in the activation of regulatory T cells by immune B cells

The transfer of B cells from mice immunized with Type III pneumococcal polysaccharide (SSS-III) results in the activation of suppressor and amplifier T cells that control the magnitude of the antibody response in recipient mice, immunized subsequently with SSS-III. Prior treatment of transferred B cells with an excess of enzyme (polysaccharide depolymerase) capable of hydrolyzing SSS-III, does not alter the capacity of these cells to activate regulatory T cells. These findings indicate that the activation of regulatory T cells by immune B cells is not mediated by residual antigen on the surface of transferred cells.

Analysis of the optimal conditions for the adsorption of type III pneumococcal polysaccharide to plastic for use in solid-phase ELISA.

An economical, sensitive enzyme-linked immunosorbent assay (ELISA) method for measuring all isotypes of immunoglobulin specific for type III pneumococcal polysaccharide (SSS-III) is described, using 96-well polystyrene microtiter plates coated directly with antigen. To achieve substantial binding of SSS-III to plastic plates, the polysaccharide had to be dissolved in a buffer (0.1 M Hepes) of pH 4.0 or less. Optimal conditions for adsorption of SSS-III to plates were found to be pH 3.5 and a concentration of 1.0 microgram SSS-III/ml (0.1 microgram/well). Under these conditions, murine anti-SSS-III polyclonal or monoclonal antibodies could be detected to a limit of about 5-10 ng/ml. The implications of these findings for assays that use mixtures of polysaccharides adsorbed to plastic plates are discussed.

T Cells Regulate the IgM Antibody Response of BALB/c Mice to Dextran B1355

The IgM antibody response of BALB/c mice to bacterial (Leuconostoc) dextran B1355 is influenced in a positive and negative manner by regulatory CD4+ and CD8+ T cells, respectively. Treatment with concanavalin A (ConA) at the time of immunization or 2 days later caused suppression and enhancement of the antibody response, respectively. Priming of mice with a sub-immunogenic dose of dextran resulted in profound suppression upon subsequent immunization 3 days later. None of these effects were demonstrable in athymic mice. Transfer of T cells from mice primed 18 h previously with a subimmunogenic dose of dextran suppressed the antibody response in immunized recipients; such suppression was abolished by the treatment of transferred cells with anti Thy 1.2 or anti Lyt 2.2 (CD8) antibody in the presence of complement. By contrast, the transfer of T cells from mice, which had been given an immunogenic dose of dextran 4 days previously, increased the antibody response in immunized recipients; such enhancement was abolished by treating transferred cells with anti Thy 1.2 or anti L3T4 (CD4) antibody in the presence of complement. These findings indicate that the immune response to dextran B1355 is regulated by CD4+ T-amplifier cells (Ta cells) and by CD8+ T-suppressor cells (Ts cells) which are activated during the course of a normal antibody response.

Lectin-induced modulation of the antibody response to type III pneumococcal polysaccharide

Several lectins were tested for their capacity to alter the antibody response to type III pneumococcal polysaccharide (SSS-III). The antibody response was enhanced by concanavalin A (Con A), phytohemagglutinin (PHA), as well as lectins from Phytolacca americana (Pa-2), Pisum sativum (PSA), and Lens culinaris (LCH), when these lectins were given 2 days after immunization with SSS-III; however, suppression was obtained when Con A and Pa-2 were given at the time of immunization. By contrast the lectins from Vicia villosa (VVL) and Bauhinia purpurea (BPA) did not alter the antibody response. Since the lectins PSA and LCH bind to the same monosaccharide as Con A, whereas the other lectins bind to different monosaccharides, these findings indicate that there is no relationship between nominal monosaccharide specificity and the capacity to modulate the antibody response. Substantial increases in the magnitude of the IgG1 antibody response was noted after the administration of Con A whereas profound enhancement of IgG2a antibody response was noted after PHA was given.

Genetic control of the antibody response to type iii pneumococcal polysaccharide in mice. Iii. Analysis of genes governing the expression of regulatory t cell activity.

Recombinant‐inbred strains of mice, as well as the progenitor strains from which they were derived, were evaluated with respect to the capacity of B cells to respond to an optimally immunogenic dose of Type III pneumococcal polysaccharide (SSS‐III) and the amount of suppressor and amplifier T cell activity present. None of these functional activities was found to be linked to genes within the major histocompatibility (H‐2) or the IgCH allotype complex, and several autosomal genes appeared to govern the expression of each of these characteristics.

Immunosuppressive Effects Induced by the Polysaccharide Moiety of Some Bacterial Lipopolysaccharides

The immunomodulatory properties of several lipopolysaccharides (LPS) derived from clinical isolates of Pseudomonas aeruginosa, Branhamella catarrhalis, and Bordetella pertussis were evaluated for their capacity to influence the magnitude of the antibody response to type III pneumococcal polysaccharide (SSS-III), which is known to be regulated by suppressor and amplifier T cells (Ts and Ta, respectively). The administration of LPS, two days after immunization resulted in a significant increase in the antibody response. Such enhancement may be due mainly to the ability of the lipid A moiety of LPS to abolish the negative effects of activated Ts, thereby enabling Ta function to be more fully expressed; however, B cell mitogenicity of the LPS molecule also may be involved. By contrast, treatment with LPS at the time of immunization with SSS-III induces significant suppression of the SSS-III-specific antibody response; such suppression is not induced by LPS or lipid A derived from Escherichia coli and Salmonella minnesota, and is independent of the capacity of LPS to activate B cells polyclonally, an activity generally attributed to the lipid A fraction of LPS. Studies conducted with the LPS of P. aeruginosa indicated that the suppression induced is T cell dependent and mediated by the polysaccharide (PS) fraction of LPS; it appears to be due-at least in part-to the capacity of PS to expand or increase the size of the precursor pool of Ts, activated in response to SSS-III. The significance of these findings to the pathogenesis of certain gram-negative infections is discussed.

Increased amplifier T cell activity in autoimmune NZB mice and its possible significance in the expression of autoimmune disease

The expression of amplifier- and helper-T cell activity was examined in NZB/N mice of different ages. Amplifier T cell activity develops in a cyclic manner; it decreases between 16 and 35 wk of age and then increases to maximal levels in mice older than 50 wk of age. The loss of suppressor T cell activity and increased amplifier T cell activity coincide with the development of autoimmune diseases in aging NZB/N mice. Although helper T cell activity is evident in young NZB/N mice, it is absent in old NZB/N mice expressing maximal amplifier T cell activity. This provides additional support for the fact that amplifier and helper functions are mediated by different subpopulations of T cells.